CRNX Operating Cash Flow (Statement)
Crinetics Pharmaceuticals Inc · Operating Cash Flow (Statement)
CRNX Operating Cash Flow (Statement)
Latest reported-$422.52Mperiod ending
CRNX TTM Cash from Operations (-$9.48M → -$422.52M)
TTM operating cash flow (statement)
High-resolution chart · PNG
CRNX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -422,515,000 | |
| -414,173,000 | |
| -377,922,000 | |
| -349,695,000 | |
| -299,773,000 | |
| -261,566,000 | |
| -225,970,000 | |
| -199,811,000 | |
| -180,354,000 | |
| -178,445,000 | |
| -166,307,000 | |
| -162,999,000 | |
| -160,139,000 | |
| -142,380,000 | |
| -115,205,000 | |
| -102,897,000 | |
| -90,091,000 | |
| -82,064,000 | |
| -88,588,000 | |
| -81,627,000 | |
| -73,958,000 | |
| -69,864,000 | |
| -62,027,000 | |
| -59,536,000 | |
| -55,139,000 | |
| -51,852,000 | |
| -46,381,000 | |
| -38,943,000 | |
| -31,029,000 | |
| -22,811,000 | |
| -19,459,000 | |
| -15,961,000 | |
| -12,711,000 | |
| -10,560,000 | |
| -9,479,000 |